{"id":"https://openalex.org/W4382181202","doi":"https://doi.org/10.1002/cpt.2983","title":"Predicting Treatment Effects of a New\u2010to\u2010Market Drug in Clinical Practice Based on Phase III Randomized Trial Results","display_name":"Predicting Treatment Effects of a New\u2010to\u2010Market Drug in Clinical Practice Based on Phase III Randomized Trial Results","publication_year":2023,"publication_date":"2023-06-27","ids":{"openalex":"https://openalex.org/W4382181202","doi":"https://doi.org/10.1002/cpt.2983","pmid":"https://pubmed.ncbi.nlm.nih.gov/37365904","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10851912"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.2983","doi":"https://doi.org/10.1002/cpt.2983","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2983","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2983","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2983","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087060030","display_name":"HoJin Shin","orcid":"https://orcid.org/0000-0002-2032-6134","observed_orcids":["https://orcid.org/0000-0002-2032-6134"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"HoJin Shin","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0002-2032-6134","affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041217714","display_name":"Shirley\u00a0V. Wang","orcid":"https://orcid.org/0000-0001-7761-7090","observed_orcids":["https://orcid.org/0000-0001-7761-7090"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shirley V. Wang","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0001-7761-7090","affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023135047","display_name":"Dae Hyun Kim","orcid":"https://orcid.org/0000-0001-7290-6838","observed_orcids":["https://orcid.org/0000-0001-7290-6838","https://orcid.org/0000-0003-4315-9145"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dae Hyun Kim","raw_affiliation_strings":["Department of Medicine, Division of Gerontology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Gerontology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056166869","display_name":"Ethan M. Alt","orcid":"https://orcid.org/0000-0002-6112-9030","observed_orcids":["https://orcid.org/0000-0002-6112-9030"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ethan Alt","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089109829","display_name":"Mufaddal Mahesri","orcid":"https://orcid.org/0000-0002-6684-2337","observed_orcids":["https://orcid.org/0000-0002-6684-2337"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mufaddal Mahesri","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030822229","display_name":"Lily Gui Bessette","orcid":"https://orcid.org/0000-0003-1088-8579","observed_orcids":["https://orcid.org/0000-0003-1088-8579"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lily G. Bessette","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0003-1088-8579","affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004416630","display_name":"Sebastian Schneewei\u00df","orcid":"https://orcid.org/0000-0003-2575-467X","observed_orcids":["https://orcid.org/0000-0003-2575-467X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sebastian Schneeweiss","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0003-2575-467X","affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044094148","display_name":"Mehdi Najafzadeh","orcid":"https://orcid.org/0000-0003-4503-1057","observed_orcids":["https://orcid.org/0000-0003-4503-1057"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210166701","display_name":"Medidata (United States)","ror":"https://ror.org/05y7kyx32","country_code":"US","type":"company","lineage":["https://openalex.org/I4210166701","https://openalex.org/I47431100"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehdi Najafzadeh","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","Currently with Medidata Solutions"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Currently with Medidata Solutions","institution_ids":["https://openalex.org/I4210166701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5087060030"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.393,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.64123672,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"114","issue":"4","first_page":"853","last_page":"861"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.04349999874830246,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10845","display_name":"Advanced Causal Inference Techniques","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":0.9380000233650208},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":1.0},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/stroke-and-systemic-embolism","display_name":"stroke and systemic embolism","score":0.9279999732971191},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.7120000123977661},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9700000286102295},{"id":"https://openalex.org/keywords/generalizability-of-trial-results","display_name":"generalizability of trial results","score":0.578000009059906},{"id":"https://openalex.org/keywords/medicare-beneficiaries","display_name":"Medicare beneficiaries","score":0.8379999995231628},{"id":"https://openalex.org/keywords/re-ly-trial","display_name":"RE-LY trial","score":0.7459999918937683},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.6119999885559082},{"id":"https://openalex.org/keywords/chads2-score","display_name":"CHADS2 score","score":0.6790000200271606},{"id":"https://openalex.org/keywords/drug-coverage-decisions","display_name":"drug coverage decisions","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8747680187225342},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.749401867389679},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.73563551902771},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.6813461184501648},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6286402940750122},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6251858472824097},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.571658730506897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.560343325138092},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5262367129325867},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5018126964569092},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.42939385771751404},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004617","descriptor_name":"Embolism","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/cpt.2983","doi":"https://doi.org/10.1002/cpt.2983","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2983","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2983","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:37365904","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37365904","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:10851912","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10851912","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10851912/pdf/nihms-1962766.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Pharmacol Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/cpt.2983","doi":"https://doi.org/10.1002/cpt.2983","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.2983","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2983","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1300416466","display_name":"Understanding effectiveness of new drugs in older adults shortly after market entry","funder_award_id":"R01AG053302","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G3468504239","display_name":"Generalizing data from randomized trials to predict long-term treatment outcomes in older populations","funder_award_id":"R01AG060163","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G4184428524","display_name":null,"funder_award_id":"RO1HL141505","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G6205496841","display_name":"Randomized Cardiovascular Trials Duplicated Using Prospective Longitudinal Insurance Claims: Applying Techniques of Epidemiology (RCT DUPLICATE)","funder_award_id":"R01HL141505","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000882695","display_name":"Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes","funder_award_id":"K24AG073527","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G9000910303","display_name":"New approaches to safety monitoring of novel systemic treatments for atopic dermatitis in clinical practice and underrepresented populations","funder_award_id":"R01AR080194","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320308347","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382181202.pdf","grobid_xml":"https://content.openalex.org/works/W4382181202.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W173724057","https://openalex.org/W1504207271","https://openalex.org/W1992646930","https://openalex.org/W1995945562","https://openalex.org/W2000991311","https://openalex.org/W2008706768","https://openalex.org/W2049491523","https://openalex.org/W2052806549","https://openalex.org/W2058881505","https://openalex.org/W2062786076","https://openalex.org/W2079491969","https://openalex.org/W2080374925","https://openalex.org/W2083035480","https://openalex.org/W2111635289","https://openalex.org/W2119910794","https://openalex.org/W2120729896","https://openalex.org/W2121394112","https://openalex.org/W2126049444","https://openalex.org/W2126728600","https://openalex.org/W2135046866","https://openalex.org/W2136489990","https://openalex.org/W2160704894","https://openalex.org/W2172245650","https://openalex.org/W2261839053","https://openalex.org/W2462394222","https://openalex.org/W2529460814","https://openalex.org/W2619335752","https://openalex.org/W2766940704","https://openalex.org/W2898559532","https://openalex.org/W2901418399","https://openalex.org/W2953682266","https://openalex.org/W2955605212","https://openalex.org/W2973316378","https://openalex.org/W3034327199","https://openalex.org/W3147894994","https://openalex.org/W3175417087","https://openalex.org/W3184824800","https://openalex.org/W4205645630","https://openalex.org/W4229873072","https://openalex.org/W4249839049","https://openalex.org/W4293802544","https://openalex.org/W4294541781"],"related_works":["https://openalex.org/W4380149258","https://openalex.org/W2790951273","https://openalex.org/W3034327199","https://openalex.org/W3028885010","https://openalex.org/W6925141592","https://openalex.org/W3195386565","https://openalex.org/W1980881195","https://openalex.org/W4200016626","https://openalex.org/W2513302822","https://openalex.org/W2418456771"],"abstract_inverted_index":{"Trial":[0],"results":[1],"may":[2,245],"not":[3],"be":[4],"generalizable":[5],"to":[6,32,179,186,193,200],"target":[7,130,212,231],"populations":[8,84,120,131,232],"treated":[9],"in":[10,36,80,94,117,229],"clinical":[11],"practice":[12],"with":[13,29,68,153],"different":[14,145,230],"distributions":[15],"of":[16,46,56,163,226],"baseline":[17,124],"characteristics":[18],"that":[19],"modify":[20],"the":[21,43,54,118,122,155,222],"treatment":[22,34,224,234],"effect.":[23],"We":[24,39,71,100],"used":[25,40],"outcome":[26,73,236],"models":[27,74,79],"developed":[28,72],"trial":[30,50,81,127],"data":[31,41,237,260],"predict":[33],"effects":[35,225,244],"Medicare":[37,87,119,157,188],"populations.":[38],"from":[42],"Randomized":[44],"Evaluation":[45],"Long\u2010Term":[47],"Anticoagulation":[48],"Therapy":[49],"(RE\u2010LY),":[51],"which":[52],"investigated":[53],"effect":[55],"dabigatran":[57,91,164],"vs.":[58,140,149,165],"warfarin":[59,93,166],"on":[60],"stroke":[61],"or":[62,92,240],"systemic":[63],"embolism":[64],"(stroke/SE)":[65],"among":[66],"patients":[67],"atrial":[69],"fibrillation.":[70],"by":[75],"fitting":[76],"proportional":[77],"hazards":[78],"data.":[82],"Target":[83],"were":[85],"trial\u2010eligible":[86],"beneficiaries":[88],"who":[89],"initiated":[90],"2010\u20132011":[95],"(\u201cearly\u201d)":[96],"and":[97,106,114,128,181,195,202,207,235],"2010\u20132017":[98],"(\u201cextended\u201d).":[99],"predicted":[101,161,243],"2\u2010year":[102],"risk":[103,107],"ratios":[104],"(RRs)":[105],"differences":[108],"(RDs)":[109],"for":[110,167,204,250],"stroke/SE,":[111],"major":[112,205],"bleeding,":[113],"all\u2010cause":[115,208],"death":[116],"using":[121],"observed":[123],"characteristics.":[125],"The":[126,210,242],"early":[129,156],"had":[132,159],"similar":[133,160,215],"mean":[134,146],"(SD)":[135],"CHADS2scores":[136],"(2.15":[137],"(SD":[138,142],"1.13)":[139],"2.15":[141],"0.91))":[143],"but":[144],"ages":[147],"(71":[148],"79":[150],"years).":[151],"Compared":[152],"RE\u2010LY,":[154],"population":[158,213],"benefit":[162],"stroke/SE":[168],"(trial":[169],"RR":[170,189],"=":[171,177,183,190,197],"0.63,":[172],"95%":[173],"confidence":[174],"interval":[175],"(CI)":[176],"0.50":[178],"0.76":[180],"RD":[182,196],"\u22121.37%,":[184],"\u22121.96%":[185],"\u22120.77%,":[187],"0.73,":[191],"0.65":[192],"0.82":[194],"\u22120.92%,":[198],"\u22121.26%":[199],"\u22120.59%)":[201],"risks":[203],"bleeding":[206],"death.":[209],"time\u2010extended":[211],"showed":[214],"results.":[216],"Outcome":[217],"model\u2010based":[218],"prediction":[219],"facilitates":[220],"estimating":[221],"average":[223],"a":[227,255],"drug":[228],"when":[233,258],"are":[238,261],"unreliable":[239],"unavailable.":[241],"inform":[246],"payers'":[247],"coverage":[248],"decisions":[249],"patients,":[251],"especially":[252],"shortly":[253],"after":[254],"drug's":[256],"launch":[257],"observational":[259],"scarce.":[262]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-06-28T00:00:00"}